アンジオポエチン
Oncogene 12 (2): 397-404. PMID 8570217.
↑ Takakura N, Watanabe T, Suenobu S, Yamada Y, Noda T, Ito Y, Satake M, Suda T (July 2000). “A role for hematopoietic stem cells in promoting angiogenesis”. Cell 102 (2): 199-209. doi:10.1016/S0092-8674(00)00025-8. PMID 10943840.
↑ Fagiani E, Christofori G (January 2013). “Angiopoietins in angiogenesis”. Cancer Letters 328 (1): 18-26. doi:10.1016/j.canlet.2012.08.018.
↑ Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, McDonald DM (Dec 1999). “Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1”. Science 286 (5449): 2511-2514. doi:10.1126/science.286.5449.2511.
↑ Amo Y, Masuzawa M, Hamada Y, Katsuoka K (May 2004). “Observations on angiopoietin 2 in patients with angiosarcoma”. Br. J. Dermatol. 150 (5): 1028-1029. doi:10.1111/j.1365-2133.2004.05932.x. PMID 15149523.
↑ Hauer AD, Habets KL, van Wanrooij EJ, et al. (October 2008). “Vaccination against TIE2 reduces atherosclerosis”. Atherosclerosis 204 (2): 365-371. doi:10.1016/j.atherosclerosis.2008.09.039. PMID 19022447.
↑ Hurliman AK, Speroff L, Stouffer RL, Patton PE, Lee A, Molskness TA (March 2010). “Changes in Circulating Levels and Ratios of Angiopoietins during Pregnancy, but not during the Menstrual Cycle and Controlled Ovarian Stimulation”. Fertil. Steril. 93 (5): 1493-1499. doi:10.1016/j.fertnstert.2009.